We are committed to building quality and equity in healthcare by leveraging innovative approaches and technologies to improve the well-being of individuals. At our core, we are dedicated to seek opportunities to provide accessible generic drugs, biosimilars, consumer healthcare products and medical devices for all.
Duopharma Biotech has 3 R&D and manufacturing facilities across the Klang Valley in Malaysia – in Klang, Bangi and Glenmarie.
Duopharma’s Consumer Healthcare portfolio include well-recognised brands in health supplements, over-the-counter medications and skincare.
Duopharma Biotech embraces the principle of a hollistic approach to halal pharmaceuticals with the “Halal Built-In, Not Tested For” practice. This ensures that our facilities and products are fully halal compliant.
Duopharma Singapore’s Pharmaceuticals portfolio consists of generic drugs that covers an extensive range of therapeutic classes. This includes cardiovascular, respiratory, sensory and nervous system, musculo-skeletal system and anti-infectives.
An overview of our pharmaceutical products can be viewed below.
Duopharma Singapore’s Medical Devices portfolio comprises a curated range of diabetes care products that aim to provide safe and efficient treatment for individuals living with diabetes.
Duopharma Singapore’s Innovative Solutions portfolio aims to introduce unique and high quality products to address the unmet medical needs of Singapore’s population.
Duopharma Singapore’s Consumer Healthcare portfolio include well-recognised brands in product segments such as vitamins, analgesics, anti-histamines, skincare and traditional medicines.
“Operational excellence drives all that we do at Duopharma Biotech and at the heart of it all, is our commitment to enabling access to healthcare for our customers. By providing smarter solutions for a healthier life, we are poised to be the leading healthcare group in Malaysia, delivering positive and tangible results for customers and shareholders alike. We continue to focus on providing smart, innovative and impactful products that offer value for money..”
Encik Wan Amir-Jeffery Bin Wan Abdul Majid
Group CEO
Generic medicines are regulated by relevant regulatory bodies in each country to ensure their quality, safety, and effectiveness. To be approved as a generic medication, it must have the same active ingredients, dosage form, strength, route of administration, and provide similar therapeutic effects as their branded counterparts. As generic medicines cost a fraction of branded ones, they are cost-effective alternatives that make medical treatment more accessible.
Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”), a leading pharmaceutical company in Malaysia, recently marked a significant milestone with the unveiling of its new regional office in German Centre, Singapore reinforcing its commitment to the Singaporean market.
Duopharma Biotech Berhad (“Duopharma Biotech”) via its subsidiary Duopharma Marketing Sdn Bhd has signed an Exclusive Distributorship Agreement with Owen Mumford Sdn Bhd, a subsidiary of UK-based medical device company Owen Mumford for the distribution of medical devices in Malaysia, Singapore, and Brunei.
Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”), a leading pharmaceutical company in Malaysia, recently marked a significant milestone with the unveiling of its new regional office in German Centre, Singapore reinforcing its commitment to the Singaporean market.